NCT06677281

Brief Summary

This systematic review aims to evaluate the impact of COVID-19 on pregnancy outcomes. It synthesizes data from various studies to provide insights into the effects of the virus on maternal and fetal health. The review focuses on key outcomes such as preterm birth, maternal complications, and neonatal health, utilizing comprehensive literature from peer-reviewed journals. By analyzing existing studies, we aim to identify trends and gaps in research regarding COVID-19 and pregnancy. This review is intended to inform healthcare providers and pregnant individuals about potential risks and considerations during the pandemic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2024

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 6, 2024

Completed
Last Updated

November 6, 2024

Status Verified

November 1, 2024

Enrollment Period

3 months

First QC Date

November 5, 2024

Last Update Submit

November 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Impact of COVID-19 on Maternal and Neonatal Outcomes

    This primary outcome measure evaluates the various maternal and neonatal outcomes associated with COVID-19 infection during pregnancy. Key metrics include rates of maternal morbidity, neonatal morbidity, preterm birth, low birth weight, and any documented complications during pregnancy, labor, and delivery. The systematic review aims to synthesize data from available studies to provide a comprehensive understanding of these outcomes and their implications for clinical practice.

    The review encompasses studies published from January 2020 to the present, with a focus on maternal and neonatal outcomes reported within the specified time frame.

Secondary Outcomes (1)

  • Effects of COVID-19 on Pregnancy-Related Complications

    The review includes data from studies published between January 2020 and the present, focusing on complications reported throughout the pregnancy and at delivery.

Interventions

This study is a systematic review of existing literature that examines the effects of COVID-19 on pregnancy outcomes, including maternal health, neonatal health, and obstetric complications. It synthesizes data from various studies to provide an overview of the potential risks associated with COVID-19 infection during pregnancy. This intervention does not involve any new clinical trials or direct patient interaction.

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of pregnant individuals diagnosed with COVID-19 as documented in various peer-reviewed studies. The review examines the impact of COVID-19 on pregnancy outcomes, including maternal health, delivery outcomes, and neonatal complications.

You may qualify if:

  • Pregnant individuals diagnosed with COVID-19.
  • Studies reporting pregnancy outcomes related to COVID-19 published between January 2020 and the present.
  • Articles that include quantitative data on maternal and fetal outcomes.

You may not qualify if:

  • Studies that do not report on COVID-19-related pregnancy outcomes.
  • Non-peer-reviewed articles or grey literature.
  • Research focusing on non-pregnant populations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zahedan University of Medical Sciences

Zahedan, Sistan and Baluchestan, Iran

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

November 5, 2024

First Posted

November 6, 2024

Study Start

May 3, 2024

Primary Completion

August 15, 2024

Study Completion

August 25, 2024

Last Updated

November 6, 2024

Record last verified: 2024-11

Locations